Study guide
Cellular & Molecular Mechanisms of Repair
ABWM Certified Wound Care Associate CWCA
Track your progress as you read
Finished sections get a check mark.
1 Introduction & CWCA Exam Overview
About the ABWM CWCA Exam CWCA Study Strategy & Exam Day Preparation
2 Wound Healing Environment
Skin Anatomy & Physiology Phases of Wound Healing Cellular & Molecular Mechanisms of Repair Factors Impeding Wound Healing Infection, Biofilm & Nutritional Support
3 Chapter 3: Wound Assessment and Diagnosis
Holistic Patient & Vascular Assessment Wound Measurement & Classification Systems NPIAP Pressure Injury Staging System Braden Scale & Risk Assessment MASD, IAD & Skin Tear Assessment Wound Documentation, Photography & Pain Management
4 Chapter 4: Patient Management and Interventions
Dressing Selection Framework & Product Categories Wound Cleansing Solutions & Topical Antimicrobials Debridement Methods Within CWCA Scope Compression Therapy & Vascular Safety Off-Loading & Pressure Redistribution Surfaces Peristomal Skin Care & Repositioning Protocols Advanced Modalities: NPWT, HBOT, CTPs & Biophysical Therapies
5 Etiological Considerations and Wound Types
Pressure Injury Etiology & Pathomechanics Venous Leg Ulcers: Pathophysiology & Care Arterial Ulcers & Lower Extremity Ischemia Diabetic Foot Ulcers & Neuropathic Assessment Surgical Wounds, Traumatic Wounds & Burns Lymphedema, Edema & Additional Wound Etiologies
6 Professional Issues and Clinical Practice
CWCA Scope of Practice & Interprofessional Boundaries Clinical Documentation, HIPAA & Bioethics Reimbursement Basics, Patient Rights & Recertification
Cellular & Molecular Mechanisms of Repair
Key Takeaways Explain This Topic AI
Growth factors (PDGF, TGF-beta, VEGF, EGF, FGF) regulate cell proliferation, chemotaxis, ECM deposition, and neovascularization through specific receptor tyrosine kinase pathways.
Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinases (TIMPs) maintain a delicate proteolytic balance during normal extracellular matrix remodeling.
In acute wounds, MMP:TIMP ratios are balanced; in chronic wounds, MMP levels increase up to 100-fold, degrading essential ECM proteins and growth factors.
The extracellular matrix consists of structural proteins (collagen types I & III), adhesive glycoproteins (fibronectin), and glycosaminoglycans (hyaluronic acid) providing mechanical support and signaling.
Chronic wound pathology is characterized by senescent cells, persistent inflammatory cytokines (TNF-alpha, IL-1beta), and high protease activity that stalls wounds in inflammation.
Last updated: July 2026
Growth Factor Signaling Cascades in Wound Repair
Growth factors are specialized polypeptide signaling molecules that bind to specific transmembrane receptors (primarily receptor tyrosine kinases) on target cell membranes. They direct cell migration (chemotaxis), cell division (mitogenesis), differentiation, and extracellular matrix (ECM) production via autocrine, paracrine, and juxtacrine signaling pathways.
Key Growth Factors & Biological Functions
Platelet-Derived Growth Factor (PDGF) :
Primary Sources : Platelet alpha-granules, activated macrophages, endothelial cells, smooth muscle cells.
Target Cells : Fibroblasts, smooth muscle cells, neutrophils, macrophages.
Functions : Potent chemoattractant for inflammatory cells and fibroblasts; directly stimulates fibroblast proliferation and type I collagen synthesis; promotes wound contraction.
Clinical Relevance : Recombinant human PDGF-BB ( Becaplermin / Regranex ) is an FDA-approved topical growth factor indicated for lower extremity neuropathic diabetic foot ulcers extending into subcutaneous tissue.
Transforming Growth Factor-Beta (TGF-beta) :
Primary Sources : Platelets, macrophages, T-lymphocytes, fibroblasts.
Functions : Master driver of ECM deposition; stimulates fibroblasts to produce collagen types I and III, fibronectin, and proteoglycans; downregulates MMP expression while upregulating TIMP synthesis.
Pathology : Dysregulated, excessive TGF-beta signaling is heavily implicated in excessive fibrosis, hypertrophic scar formation, and keloids .
Vascular Endothelial Growth Factor (VEGF) :
Primary Sources : Macrophages, keratinocytes, fibroblasts (stimulated by local hypoxia via HIF-1alpha).
Target Cells : Endothelial cells.
Functions : Primary driver of angiogenesis; induces endothelial cell migration, proliferation, and microvascular permeability.
Epidermal Growth Factor (EGF) & Transforming Growth Factor-Alpha (TGF-alpha) :
Primary Sources : Platelets, macrophages, submandibular glands.
Target Cells : Keratinocytes, epithelial cells.
Functions : Accelerates re-epithelialization by stimulating keratinocyte proliferation and migration across the wound bed.
Fibroblast Growth Factors (FGF-1 / Acidic FGF, FGF-2 / Basic FGF) :
Primary Sources : Macrophages, endothelial cells, chondrocytes.
Functions : Stimulates fibroblast proliferation, granulation tissue formation, and endothelial cell migration.
Matrix Metalloproteinases (MMPs) vs. TIMPs Equilibrium
Matrix Metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases secreted by neutrophils, macrophages, fibroblasts, keratinocytes, and endothelial cells. In physiological tissue repair, MMPs function to degrade damaged ECM components, facilitate cell migration through dense matrix barriers, and participate in scar remodeling.
Classification of Major MMPs
Interstitial Collagenases (MMP-1, MMP-8, MMP-13) : Cleave native, triple-helical collagen types I, II, and III. MMP-1 is produced primarily by keratinocytes and fibroblasts; MMP-8 is released by neutrophils.
Gelatinases (MMP-2, MMP-9) : Degrade denatured collagen (gelatin), type IV basement membrane collagen, fibronectin, and elastin. MMP-9 is heavily released by PMNs during inflammation.
Stromelysins (MMP-3, MMP-10) : Cleave proteoglycans, laminin, fibronectin, and activate pro-MMP precursor zymogens.
Tissue Inhibitors of Metalloproteinases (TIMPs)
To prevent uncontrolled tissue destruction, active MMPs are strictly regulated by endogenously produced inhibitors known as Tissue Inhibitors of Metalloproteinases (TIMPs 1–4) . TIMPs bind to active MMP catalytic sites in a 1:1 stoichiometric ratio , neutralizing their enzymatic activity. ACUTE WOUND (Balanced Environment):
[Low/Transient MMPs] : [High/Adequate TIMPs] ──> Controlled ECM Turnover & Healing
CHRONIC WOUND (Proteolytic Imbalance):
- [MMPs Elevated 10-100x] : [Low/Suppressed TIMPs] ──> ECM Destruction & Growth Factor Degradation
- Proteolytic Imbalance in Chronic Wounds
In healthy acute wounds, MMP levels rise briefly during early inflammation and proliferation to clear damaged tissue, rapidly normalizing as TIMP levels rise.
In chronic non-healing wounds (e.g., chronic venous leg ulcers, pressure injuries, diabetic foot ulcers), this homeostatic balance collapses:
MMP levels are elevated 10 to 100 times higher than in acute wounds.
TIMP levels are markedly depressed .
Result : The overwhelming excess of active proteases (MMP-2, MMP-8, MMP-9, and neutrophil elastase) non-selectively degrades newly deposited collagen, cleaves fibronectin migration tracks, destroys endogenous growth factors (PDGF, VEGF), and inactivates growth factor cell surface receptors.
Extracellular Matrix (ECM) Components & Dynamics
The Extracellular Matrix (ECM) is a dynamic 3D structural and functional network that provides physical scaffolding for cells, stores growth factors, and transmits mechanical and biochemical signals that regulate cell behavior.
ECM Category Key Molecular Components Primary Structural & Biological Role
Structural Proteins Collagen Type I (80%), Collagen Type III (15%), Elastin Provides tensile strength, tissue architecture, and elastic recoil
Adhesive Glycoproteins Fibronectin, Vitronectin, Laminin-332 Serves as molecular "glue" linking cells to ECM via integrin receptors
Glycosaminoglycans (GAGs) Hyaluronic Acid (Hyaluronan), Chondroitin Sulfate High water-binding capacity; creates hydrated gel matrix for cell motility
Proteoglycans Versican, Decorin, Perlecan Regulates GAG assembly, growth factor binding, and collagen fibrillogenesis
Fibronectin & Hyaluronic Acid in Early Repair
Fibronectin : Acts as a vital bridging protein. Plasma fibronectin incorporates into the provisional fibrin clot, while tissue fibronectin is secreted by fibroblasts. Integrin cell receptors (such as alpha-5-beta-1) bind to fibronectin's RGD (Arg-Gly-Asp) amino acid sequence, enabling keratinocytes and fibroblasts to march across the wound bed.
Hyaluronic Acid (Hyaluronan) : A massive, non-sulfated glycosaminoglycan with immense osmotic water-binding capacity. In early wound healing, hyaluronan expands the interstitial space, forming a porous, highly hydrated matrix that facilitates cell motility, nutrient diffusion, and early tissue swelling.
Molecular Pathology of Chronic Non-Healing Wounds
When acute wounds fail to progress through the orderly phases of repair, they become trapped in a self-perpetuating chronic inflammatory loop .
Features of the Chronic Wound Microenvironment
Persistent Inflammatory Infiltrate : Continuous influx of hyperactive neutrophils releasing high levels of pro-inflammatory cytokines ( TNF-alpha , IL-1beta , IL-6 ).
Elevated Protease & ROS Activity : Massive excess of MMP-8, MMP-9, elastase, and reactive oxygen species that destroy healthy matrix components faster than fibroblasts can synthesize them.
Growth Factor Inactivation : Endogenous growth factors (PDGF, VEGF, TGF-beta) are degraded within hours of secretion by excessive proteases.
Phenotypic Cellular Senescence : Chronic wound fibroblasts and endothelial cells become senescent . Although structurally present, these cells exhibit altered morphology, reduced proliferative capacity, diminished responsiveness to growth factor stimulation, and decreased collagen synthesis capability.
Clinical Takeaway: Advanced wound therapies—such as collagen dressings, oxidized regenerated cellulose (ORC)/collagen matrices, and bioengineered skin equivalents—work by binding and neutralizing excess MMPs, sacrificing themselves to protect endogenous growth factors and restore molecular equilibrium.